-
Symbol
-
APUS on NYSE
-
Investment type
-
Equity / Common stock, par value $0.01 per share
-
Latest Disclosed Shares Owned
-
1,397,021 shares
-
Security Ownership %
-
10%
Ayrton Capital LLC ownership in Apimeds Pharmaceuticals US, Inc. Common stock, par value $0.01 per share (APUS)
11 Feb 2026 - Ayrton Capital LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,397,021 shares of Apimeds Pharmaceuticals US, Inc. Common stock, par value $0.01 per share (APUS).
This represents 10% ownership of the company.
This is the first filing by Ayrton Capital LLC disclosing ownership of Apimeds Pharmaceuticals US, Inc. Common stock, par value $0.01 per share (APUS).